ArticleFrontiers in immunology2021

Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio.

Alberto Bongiovanni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.